Reagents required to pre-screen blood products for donation. Failure to acquire these reagents would result in a total work stoppage.
Ended Awarded Last action
- Contract number
- HT009026FG1130065
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,641
Award facts
- Contract value 100% obligated
- $24,640.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded Abbott Laboratories Inc., through its Abbott Diagnostics Division, a Blanket Purchase Agreement (BPA) call valued at $24,640.62 on November 25, 2025, for reagents required to pre-screen blood products for donation. The contract is classified as Firm Fixed Price and will be performed in North Chicago, Illinois, with an ultimate completion date of September 30, 2026. This award was made without a set-aside designation, demonstrating Abbott's ability to compete effectively in the unrestricted federal marketplace. The reagents are critical to military blood banking operations, and the contracting description notes that failure to acquire these materials would result in total work stoppage, underscoring the mission-critical nature of this procurement.
This award represents a delivery order call against one of Abbott's existing Defense Health Agency master contract vehicles for blood product screening consumables and immunochemistry reagents. Abbott has established itself as a strategic supplier to the Defense Health Agency and broader federal healthcare system, maintaining multiple indefinite delivery vehicles and BPAs totaling over $200 million in cumulative obligated amounts across the Department of Veterans Affairs and Defense Health Agency. The company's Abbott Diagnostics Division specializes in providing sophisticated laboratory analyzers, diagnostic solutions, and associated consumables—including chemistry and immunoassay systems, infectious disease testing equipment, and blood banking capabilities—that enable federal healthcare organizations to conduct comprehensive patient diagnostic testing and support essential medical operations.
Quick answers
Who was awarded contract HT009026FG1130065?
HT009026FG1130065 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on November 25, 2025.
How much is contract HT009026FG1130065 worth?
The government has obligated $24,641 on HT009026FG1130065.
Is contract HT009026FG1130065 an order under another contract?
Yes. HT009026FG1130065 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009026FG1130065 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award